Market Watch of WSJ.com fames reports that a Life Science Intelligence study predicts that the global market for percutaneous closure devices will exceed $1 Billion, yes $1 Billion by 2013.
From Market Watch Abbott pharmaceutical reports a 34% increase in 2nd quarter profits over last year. Vascular products sales increased 16% to $490 million, with sales of coronary stents increased 30% to $217 million. Abbott's new drug-coated stent, Xience, was approved for the U.S. market in early July. The product has already been on the market in Europe for some time.
Market Watch quarterly earnings from J & J. J & J. Definately one for the college fund.
Medtronics reports flat earning on charges from Market Watch
Comments